INVO Bioscience to Report First Quarter 2021 Financial Results on Monday, May 17, 2021

b'SARASOTA, Fla., May 11, 2021 /PRNewswire/ --INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world\'s only in vivo Intravaginal Culture System (IVC), INVOcell, an effective and affordable treatment for patients diagnosed with infertility, will report financial results for its first quarter 2021, ended March 31, 2021, after the market close on Monday, May 17, 2021.